Representing Animals Foundation
15.5.2024 21:04:31 CEST | ACCESS Newswire | Press release
SOUTHAMPTON, ENGLAND / ACCESSWIRE / May 15, 2024 / A new study has increased confidence in the apparent benefits of vegan diets for dogs. The study reanalysed data within a key 2022 study of 2,536 dogs - the largest published study within this field. That study concluded that the healthiest and least hazardous dog foods were nutritionally-sound vegan diets. However, owner opinions of health were included, which may not always be reliable. For example, owners committed to feeding vegan or meat-based diets might sometimes fail to recognise or report subsequent health problems.
The new study used additional statistical methods, including machine learning, to analyse owner opinions of health. It found these were minimally affected when vegan diets were fed. Stated Prof. Andrew Knight - lead author of the original study, "I was relieved to see confirmation that feeding vegan diets had minimal impact on owner opinions about health. This increases my confidence in the reliability of the owner opinions we used."
The new study focused specifically on subjective owner opinions of health, in contrast to the original study which examined seven general indicators of illness, including more objective data such as the frequency of medication use, therapeutic diet use, and veterinary visits. The original study also analysed the reported assessments of veterinarians concerning dog health, as well the prevalence of 22 of the most common health disorders in dogs. Stated Knight, "The large number of health parameters we studied, and the very large number of dogs included, provide a high degree of confidence in the results."
By May 2024 there were 10 studies in dogs, and three in cats, demonstrating equivalent or superior health outcomes when vegan diets are fed, as well as one systematic review covering both species. In April 2024, the longest, most comprehensive peer-reviewed study demonstrated that dogs fed nutritionally-sound vegan diets maintained health outcomes as well as those fed meat. The study comprehensively analysed blood cells and biochemistry, blood nutrient levels, urine, veterinary clinical parameters, and monthly pet owner questionnaires. It studied 15 dogs fed solely vegan diets for an entire year - just under one tenth of an average dog lifespan, or around seven human years. Another 2022 study demonstrated that 1,052 dogs fed vegan diets lived 1.5 years longer, on average, than dogs fed meat. Stated Prof. Knight, "This equates to around an extra decade of life for a human. Additionally, dogs fed vegan diets appear less impacted by certain health problems that impair quality of life. However, it is essential that any diets fed be nutritionally-sound."
Prof. Knight also analysed the environmental benefits of vegan pet diets in a major recent study. This demonstrated that if all the world's pet dogs went vegan, more greenhouse gases than those emitted by the UK would be saved. Knight stated that "Climate change is becoming a major threat to life on Earth. With the livestock sector a leading cause, substantial dietary change is now essential, and that includes pet diets."
Contact Information
Andrew Knight
Veterinary Professor of Animal Welfare
andrew.knight@winchester.ac.uk
SOURCE: Prof. Andrew Knight
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Fermi Announces Second Quarter 2026 Earnings Release and Call Date20.7.2026 22:30:00 CEST | Press release
Fermi to host earnings call on August 13, 2026 DALLAS, TX / ACCESS Newswire / July 20, 2026 / Fermi Inc. (NASDAQ:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), announced today that it plans to release second quarter 2026 financial results at 7 a.m. Eastern Time / 12 p.m. British Time on Thursday, August 13, 2026. This announcement will be followed by an earnings conference call at 9 a.m. Eastern Time / 2 p.m. British Time. The Company's earnings release and supplemental information will be posted to the Investors section of the Company's website prior to the conference call. To join the live conference call, dial 888-506-0062 in the U.S. or +1 973-528-0011 internationally approximately 15 minutes prior to the scheduled start time and refer to conference code 587288. The call will also be webcast in a listen-only mode and can be accessed through the Investor Relations Events & Presentations page of Fermi's website. A replay of the webcast will be available for
GA-ASI and KONGSBERG Advance JSM Integration for MQ-9B20.7.2026 12:05:00 CEST | Press release
Companies Bring Joint Strike Missile Weapon System to Leading Uncrewed Platform SAN DIEGO, CA / ACCESS Newswire / July 20, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) and KONGSBERG Gruppen ASA (KONGSBERG) completed the System Requirements Review (SRR) and Preliminary Design Review (PDR) for the integration of the Joint Strike Missile (JSM) weapon system onto MQ-9B. This design and integration effort is a jointly funded project by both companies aimed at providing long-range strike capability for MQ-9B and its customers. These reviews were successfully completed in Kongsberg, Norway, on June 30. MQ-9B is an industry-leading uncrewed aircraft system (UAS) manufactured by GA-ASI and includes the SkyGuardian® and SeaGuardian® models. KONGSBERG produces the JSM, a best-in-class weapon system for use against high-priority targets. "We recognize the value JSM brings to our MQ-9B platform," said Niki Johnson, GA-ASI Vice President, International Capture and Government Affairs. "
GA-ASI Completes Qualification Testing for UK Protector Weapons20.7.2026 12:00:00 CEST | Press release
Concludes 6-Year U.S. and U.K. Governmental and Industry Collaboration SAN DIEGO, CA / ACCESS Newswire / July 20, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) has completed weapons testing for the Royal Air Force's (RAF) Protector RG Mk1 Remotely Piloted Aircraft, qualifying both the Paveway IV laser-guided bomb and the Brimstone 3 air-to-surface missile for launch from GA-ASI's MQ-9B aircraft. Testing was completed on June 18 at GA-ASI's facilities in Southern California and marked the first time that GA-ASI has taken the lead role in completing weapons qualification for a customer. The qualification testing was conducted under UK Ministry of Defence approval and met all requirements for certification of the safe carriage and release of weapons. "The Royal Air Force is our MQ-9B launch customer and we're here to support them in any way we can," said GA-ASI President David R. Alexander. "Leading the qualification test was a unique experience and we're excited to complete
ePropelled to Showcase Next Generation Electric Propulsion, Software Innovation and Autonomous Systems Capabilities at Farnborough International Airshow 202617.7.2026 17:00:00 CEST | Press release
Meet the ePropelled team in Hall 2, Stand 2039, on the New Hampshire Mission Pavilion FARNBOROUGH, UK / ACCESS Newswire / July 17, 2026 / ePropelled, a leading global provider of smart propulsion solutions and energy management systems, will exhibit at the Farnborough International Airshow 2026, showcasing its latest innovations for aerospace, defense and uncrewed vehicle applications. Visitors to Hall 2, Stand 2039 on the New Hampshire Mission Pavilion will have the opportunity to meet the ePropelled team and learn about a range of exciting developments, including new product launches, software innovations, technology updates and exclusive previews of next-generation solutions currently in development. With autonomy, electrification and intelligent mobility driving the future of aerospace and defence, ePropelled continues to develop advanced propulsion, power management and software technologies that enhance performance, efficiency and mission capability across air, land and maritime
As the UK Backs Life Sciences and Advanced Manufacturing, US PMO Firm MustardSeed Moves In to Help Deliver It16.7.2026 11:00:00 CEST | Press release
The expansion reflects growing client demand for embedded programme management support across highly regulated industries. WEST CHESTER, PA AND MANCHESTER, UK / ACCESS Newswire / July 16, 2026 / The UK Government's 2025 Modern Industrial Strategy has put life sciences, advanced manufacturing, defence, and clean energy at the centre of Britain's growth agenda. MustardSeed, a US-based programme management and PMO consultancy, is launching UK operations to help organisations in those sectors deliver on that ambition. The 2025 Modern Industrial Strategy names life sciences and advanced manufacturing among its eight priority sectors, alongside defence and clean energy. These are industries defined by complex, regulated, multi-stakeholder programmes where disciplined execution directly determines commercial and operational outcomes. MustardSeed, headquartered in West Chester, Pennsylvania, has built its practice around delivering that execution. The firm announced today the launch of its UK
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
